19 June 2013
Keywords: gsk, hycamtin, gets, positive, chmp, feedback, uk
Article | 05 December 2005
UK drug major GlaxoSmithKline says that Hycamtin (topotecan powder), the firm's treatment for relapsed small-cell lung cancer, has received a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 December 2005
18 June 2013
© 2013 thepharmaletter.com